|
SPCS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.300600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.734250E-02 |
| Normal-vs-Stage2 |
8.417600E-01 |
| Normal-vs-Stage3 |
2.563200E-03 |
| Normal-vs-Stage4 |
1.855690E-03 |
| Stage1-vs-Stage2 |
1.389990E-01 |
| Stage1-vs-Stage3 |
2.006000E-01 |
| Stage1-vs-Stage4 |
1.387980E-01 |
| Stage2-vs-Stage3 |
3.791900E-02 |
| Stage2-vs-Stage4 |
2.714100E-02 |
| Stage3-vs-Stage4 |
6.596200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.620050E-03 |
| Normal-vs-AfricanAmerican |
9.595200E-01 |
| Normal-vs-Asian |
1.034400E-02 |
| Caucasian-vs-AfricanAmerican |
7.714400E-02 |
| Caucasian-vs-Asian |
9.498200E-01 |
| AfricanAmerican-vs-Asian |
1.187040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.315300E-03 |
| Normal-vs-Female |
1.295900E-02 |
| Male-vs-Female |
4.920000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.237000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.881500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.826000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.189200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.402800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.033600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.419000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.716000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.804400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.988000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.633700E-02 |
| Classical-VS-Follicular |
6.736400E-02 |
| Classical-VS-Other |
2.044200E-01 |
| Classical-VS-Normal |
2.515800E-03 |
| Tall-VS-Follicular |
2.039300E-03 |
| Tall-VS-Other |
8.266400E-01 |
| Tall-VS-Normal |
6.16660000000158E-05 |
| Follicular-VS-Other |
1.709430E-01 |
| Follicular-VS-Normal |
7.633800E-01 |
| Other-VS-Normal |
1.234960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.168180E-01 |
| Normal-vs-N1 |
4.05100000000491E-05 |
| N0-vs-N1 |
4.819200E-03 |
|
|
